These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7270403)

  • 21. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol.
    Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD
    Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of congestive heart failure: neuroendocrine approach.
    Shmuely H; Sclarovsky S; Rosenfeld JB
    Isr J Med Sci; 1993 Jan; 29(1):6-10. PubMed ID: 8454456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
    Wilmshurst PT; Thompson DS; Juul SM; Dittrich HC; Dawson JR; Walker JM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1985 May; 53(5):493-506. PubMed ID: 3994862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-digitalic cardiac inotropic agents].
    Méndez R
    Arch Inst Cardiol Mex; 1981; 51(3):201-5. PubMed ID: 7283531
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathophysiology of cardiac failure.
    Weber KT; Janicki JS; Maskin CS
    Am J Cardiol; 1985 Jul; 56(3):3B-7B. PubMed ID: 4025157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS
    Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Positive inotropic agents. Generalities and classification].
    Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
    Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic effects of various doses of a new inotropic: amrinoma].
    Cárdenas M; Vidaurri A
    Arch Inst Cardiol Mex; 1979; 49(5):961-8. PubMed ID: 122781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
    Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Right ventricular hemodynamics and lung function following amrinone injection].
    Klepzig M; Baur X; Hauser F; Mernitz G; Fruhmann G; Strauer BE
    Z Kardiol; 1984 Oct; 73(10):623-7. PubMed ID: 6516514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined vasodilator and inotropic therapy of heart failure: experimental and clinical concepts.
    Miller RR; Palomo AR; Brandon TA; Hartley CJ; Quinones MA
    Am Heart J; 1981 Sep; 102(3 Pt 2):500-8. PubMed ID: 7023220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer inotropic agents.
    Sharpe DN
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):215-8. PubMed ID: 6087050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New positive inotropic agents for congestive heart failure.
    N Engl J Med; 1986 Aug; 315(6):396-7. PubMed ID: 3736614
    [No Abstract]   [Full Text] [Related]  

  • 39. [New drugs with positive inotropic action].
    Bijak A; Czołpiński T
    Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
    [No Abstract]   [Full Text] [Related]  

  • 40. Amrinone in the management of low cardiac output after open heart surgery.
    Goenen M; Pedemonte O; Baele P; Col J
    Am J Cardiol; 1985 Jul; 56(3):33B-38B. PubMed ID: 4025158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.